Genecker

Seoul, South Korea · Founded 2017 · $6.3M raised

Headquarters
Seoul
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$6.3M
Last Round
$6.3M Series AMay 2022
Rounds
1

About

GeneCker Co., Ltd. is a South Korean biotechnology company pioneering CRISPR/Cas9-enhanced liquid biopsy cancer diagnostics, founded in 2017 in Seoul. The company's flagship products — CRISPincette™ and ONCOseeker™ — combine ultra-precision CRISPR gene-editing with next-generation sequencing (NGS) to detect low-frequency cancer mutations in blood samples with greater sensitivity than conventional NGS. GeneCker holds international patents in the US, Europe, Japan, and China, and has ISO 13485 certification for in vitro diagnostic manufacturing.

Summary

Genecker is a Biotech company based in Seoul, South Korea, founded in 2017. It has raised $6.3M in total across 1 round, most recently a $6.3M Series A round in May 2022. Investors include Premier Inc., UTC Investment and Magna Capital Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2022
$6.3M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genecker on Indexed.vc
<a href="https://indexed.vc/companies/genecker"><img src="https://indexed.vc/api/badge/company/genecker" alt="Genecker on Indexed.vc" width="260" height="76" /></a>